Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-16T15:22:07.721Z Has data issue: false hasContentIssue false
  • English
  • Français

The Role of Estrogen Therapy in Postpartum Psychiatric Disorders: An Update

Published online by Cambridge University Press:  07 November 2014

Salvatore Gentile
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives:

The aim of this review is to assess and summarize the existing literature data about the efficacy of estrogen replacement therapy (ERT) in preventing and treating postpartum psychiatric disorders.

Methods:

An extensive and unrestrictive computerized search (from 1970 to June 2005) on MEDLINE/PubMed, TOXNET, EMBASE, and Cochrane Databases was conducted with the following search terms: estradiol, estrogen-treatment, hormonal treatment, therapy, postpartum depression, postnatal depression, puerperal depression, postpartum blues, postpartum psychosis, lactation, and breastfeeding.

Results:

In assessing available literature information about the role of ERT in preventing and treating puerperal psychiatric diseases, all reviewed studies were found to suffer from severe methodological limitations.

Conclusion:

Well-designed and strictly focused multicenter trials are warranted in order to firmly establish the effectiveness of ERT in puerperal psychiatric disorders.

Type
Original Research
Information
CNS Spectrums , Volume 10 , Issue 12 , December 2005 , pp. 944 - 953
Copyright
Copyright © Cambridge University Press 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Rapkin, AJ, Mikacich, JAMoatakef-Imani, B. Reproductive mood disorders. Primary Psychiatry. 2003;10:31–40.Google Scholar
2.Stocky, A, Lynch, J. Acute psychiatric disturbance in pregnancy and the puerperium. Bailliercs Best Pract Res Clin Obstet Gynaecol. 2000;14:73–87.Google Scholar
3.Weimberg, MK, Tronick, EZ. The impact of maternal psychiatric illness on infant development. J Clin Psychiatry. 1998;59(suppl 2):53–61.Google Scholar
4.Niemi, TL, Suvisaari, JM, Haukka, JK, Wrede, G, Lonnqvist, JK. Cumulative incidence of mental disorders among offspring of mothers with psychotic disorder. Br J Psychiatry. 2004;185:11–17.CrossRefGoogle ScholarPubMed
5.Murray, L, Cooper, PJ. Postpartum Depression and Child Development. London, England: Guilford Press, 1997.Google Scholar
6.Diego, MA, Field, T, Hernandez-Reif, M, Cullen, C, Schanberg, S, Kuhn, C. Prepartum, postpartum, and chronic depression effects on newborns. Psychiatry. 2004;67:63–80.Google Scholar
7.Rahman, A, Iqhal, Z, Bunn, J, Lovel, H, Harrington, R. Impact of maternal depression on infant nutritional status and illness: a cohort study. Arch Gen Psychiatry. 2004;61:946–952.Google Scholar
8.Jones, HW, Venis, A. Identification and classification of postpartum psychiatric disorders. J Psychol Nursing. 2001;39:23–29.Google Scholar
9.Llewellyn, AM, Stowe, ZN, Nemeroff, CB. Depression during pregnancy and the puerperium. J Clin Psychiatry. 1997;58(suppl 15):26–32.Google ScholarPubMed
10.Seyfred, LS, Marcus, SM. Postpartum mood disorders. Int Rev Psychiatry. 2003;15:231–242.CrossRefGoogle Scholar
11.O'Hara, MW, Schlechte, JA, Lewis, DA, Wright, EJ. Prospective study of postpartum blues: biologic and psychosocial factors. Arch Gen Psychiatry. 1991;48:801–806.Google Scholar
12.Campbell, SB, Cohn, JF, Flanaghan, C. Course and correlates of postpartum depression during the transition to parenthood. Dev Psychopathol. 1992;4:29–47.CrossRefGoogle Scholar
13.Kendell, RE, Chalmers, JC, Plat, C. Epidemiology of puerperal psychosis. Br J Psychiatry. 1987;150:662–673.CrossRefGoogle Scholar
14.Watson, JP, Elliott, SA, Rugg, AJ, Brough, DI. Psychiatric disorder in pregnancy and the first postnatal year. Br J Psychiatry. 1984;144:453–462.CrossRefGoogle ScholarPubMed
15.Georgiopoulos, AM, Bryan, TL, Yawn, BP, Houston, MS, Rummans, TA, Therneau, TM. Population-based screening for postpartum depression. Br J Psychiatry. 1999;93:653–657.Google ScholarPubMed
16.Robertson, E, Grace, S, Wallington, T, Stewart, DE. Antenatal tisk factors for postpartum depression: a synthesis of recent literature. Gen Hosp Psychiatry. 2004;26:289–295.Google Scholar
17.Cohen, LS, Nonacs, R, Viguera, AC, Reminick, A. Diagnosis and treatment of depression during pregnancy. CNS Spectr. 2004;9:209–216.Google Scholar
18.Dennis, CLE, Stewart, DE. Treatment of postpartum depression, part 1: a critical review of biological interventions. J Clin Psychiatry. 2004;65:1242–1251.CrossRefGoogle ScholarPubMed
19.Pfuhlmann, B, Stoeber, G, Beckmann, H. Postpartum psychosis: prognosis, risk factors, and treatment. Curr Psychiatry Rep. 2002;4:185–190.CrossRefGoogle ScholarPubMed
20.Freeman, MP, Smith, KW, Freeman, SA, et al.The impact of reproductive events on the course of bipolar disorder in women. J Clin Psychiatry. 2002;63:284–287.Google Scholar
21.Stowe, ZN, Nemeroff, CB. Women at risk of postpartum-onset major depression. Am J Obstet Gynecol. 1995;173:639–645.Google Scholar
22.Rohde, A, Marneros, A. Postpartum psychosis: onset and long tetm course. Psychopathology. 1993;26:203–209.CrossRefGoogle Scholar
23.Attta, E, Downey, J, Oberman, M. Postpartum psychosis. In: Miller, LJ, ed. Postpartum Mood Disorder. Washington DC: American Psychiatric Press. 1999:99–117.Google Scholar
24.Parry, BL. Postpartum psychiatric syndromes. In: Kaplan, HI, Sadock, B, eds. Comprehensive Textbook of Psychiatry. vol. 1. 6th ed. Philadelphia, Penn: William & Wilkins; 1995:1059–1066.Google Scholar
25.Brockington, I. Postpartum psychiatric disorders. Lancet. 2004;363:303–310.Google Scholar
26.Bokhari, R, Bhatara, VS, Bandettini, F, McMillin, JM. Postpartum psychosis and postpartum thyroiditis. Psychoneuroendocrinol. 1998;23:643–650.CrossRefGoogle ScholarPubMed
27.Harris, B, Lovett, L, Smith, J, Read, G, Walker, R, Newcombe, R. Cardiff puerperal mood and hormone study. III. Postnatal depression at 5 to 6 weeks postpartum, and its hormonal correlates across the postpartum period. Br J Psychiatry. 1996;168:739–744.Google Scholar
28.Harris, B, Johns, S, Fung, H, et al.The hormonal environment of post-natal depression. Br J Psychiatry. 1989;154:660–667.Google Scholar
29.Suzuki, S, Dennerstein, L, Greenwood, KM, Armstrong, SM, Sano, T, Satohisa, E. Melatonin and hormonal changes in disturbed sleep during late pregnancy. J Pineal Res. 1993;15:191–198.Google Scholar
30.Parry, BL, Sorenson, DL, Meliska, CJ, et al.Hormonal basis of mood and postpartum disorders. Curr Women's Health Rep. 2003;3:230–235.Google ScholarPubMed
31.Bloch, M, Schimdt, PJ, Danaceau, M, Murphy, J, Nieman, L, Rubinow, DR. Effects of gonadal steroids in women with history of postpartum depression. Am J Psychiatry. 2000;157:924–930.Google Scholar
32.Born, L, Zinga, D. Challenges in identifying and diagnosing postpartum disorders. Primary Psychiatry. 2004;11:29–36.Google Scholar
33.Willcox, DL, Yovich, JI, McColm, SC, Phillips, JM. Progesterone, Cortisol and estradiol-17 beta in the initiation of human parturition: partitioning between free and bound hormone in plasma. Br J Obstet Gynaecol. 1985;92:65–71.Google Scholar
34.Hendrick, V, Altshuler, LL, Suri, R. Hormonal changes in the postpartum and implications for postpartum depression. Psychosomatics. 1998;39:93–101.Google Scholar
35.Shors, TJ, Leuner, B. Estrogen-mediated effects on depression and memory formations in females. J Affect Disord. 2003;74:85–96.Google Scholar
36.Backstrom, T, Cartensen, H, Sodegard, R. Concentration of estradiol, testosterone and progesterone in cerebrospinal fluid compared to unbound and total concentrations, J Steroid Biochem. 1976:7:469–472.Google Scholar
37.Schwartz, S, Pohl, P. Steroid hormones and steroid hormone binding globulins in cerebrospinal fluid studied in individuals with intact and with disturbed blood-cerebrospinal fluid barrier. Neuroendocrinology. 1992;55:174–182.Google Scholar
38.Rapkin, AJ, Mikacich, JA, Moatakef-Imani, B, Ragson, N. The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders. Curr Psychiatry Rep. 2002;4:419–428.Google Scholar
39.Nott, PN, Franklin, M, Armitage, C, Gelder, MG. Hormonal changes in mood and puerperium. Br J Psychiatry. 1976;128:379–383.Google Scholar
40.O'Hara, MW, Schlechte, JA, Lewis, DA, Wright, EJ. Controlled prospective study of postpartum mood disorders: psychological, environmental, and hormonal variables. J Abnorm Psychol. 1991;100:63–73.Google Scholar
41.Schimdt, PJ, Neiman, LK, Danaeau, MA, Adams, LF, Rubinow, DR. Differenytial behavioral effects on gonadal steroids in women with and those without premenstrual syndrome. Sem Reprod Endocrionol. 1998;15:91–100.Google Scholar
42.Rubinow, DR, Schmidt, PJ, Roca, CA. Estrogen-serotonin interactions: implication for affective regulation. Biol Psychiatry. 1998;44:839–850.CrossRefGoogle ScholarPubMed
43.McEwen, BS, Alves, SE. Estrogen actions in the central nervous system. Endocrin Rev. 1999;20:279–307.Google Scholar
44.Rupprecht, R, Holsboer, F. Neuroactive steroids: mechanism of action and ncuropsychopharmacological perspectives. Trend Neurosci. 1999;22:410–416.Google Scholar
45.Payne, JL. The role of estrogen in mood disorders in women. Int Rev Psychiatry. 2003;15:280–290.Google Scholar
46.Ahokas, A, Marjatta, A, Rimón, R. Positive treatment effect of estradiol in postpartum psychosis: a pilot study. J Clin Psychiatry. 2000;61:166–169.Google Scholar
47.Fink, G, Sumner, BE, Rosie, R, Grace, O, Quinn, JP. Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol Neurobiol. 1996;16:325–344.Google Scholar
48.Luine, VN, Khylchevskaya, RI, McEven, B. Effects of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain. Brain Res. 1975;86:293–306.Google Scholar
49.Riecher-Rössler, A. Association between ocstradiol and puerperal psychosis. Acta Psychiatr Scand. 2000;101:169–170.Google Scholar
50.McEwen, BS, Nongenomic and genomic effects of steroids on neural activity. Trend Pharmacol Sci. 1991;12:141–147.Google Scholar
51.O'Malley, BW, Means, AR. Female steroid hormones and target cell nuclei. Science. 1974;183:610–620.Google Scholar
52.Magiakou, MA, Mastorakos, G, Rabin, D, Dubbert, B, Gold, PW, Chrousos, GP. Hypothalamic corticotropin-releasing hormone suppression during the post-partum period: implications for the increase of psychiatric manifestations in this period. J Clin Endocrinol Metab. 1996;81:1912–1917.Google Scholar
53.Cizza, G, Chrousos, GP. High-dose transdermal estrogen, corticotrophin-releasing hormone, and postnatal depression [letter]. J Clin Endocrinol Metab. 1997;82:704.Google Scholar
54.Warner, R, Appleby, L, Whitton, A, Faragher, B. Demographic and obstetric risk factors for postnatal psychiatric morbidity. Br J Psychiatry. 1996;168:139–144.Google Scholar
55.Cookson, JC. The neuroendocrinology of mania, J Affect Disord. 1985;8:233–241.Google Scholar
56.Wieck, A, Kumar, R, Hirst, AD, Marks, MN, Campbell, IC, Checkley, SA. Increased sensitivity of dopamine receptors and recurrence of affective psychosis after childbirth. Br Med J. 1991;303:613–616.CrossRefGoogle ScholarPubMed
57.Joffe, H, Cohen, LS. Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge? Biol Psychiatry. 1998;44:798–811.Google Scholar
58.Gotlib, JH, Whiffen, VE, Mount, JH, Milne, K, Cordy, NI. Prevalence and demographic characteristics associated with depression in pregnancy and the postpartum, J Consult Clin Psychol. 1989;57:269–274.Google Scholar
59.O'Hara, MWPostpartum Depression: Causes and Consequences. New York, NY: Springer-Verlag; 1995.Google Scholar
60.Dennis, CLE, Janssen, PA, Singer, J. Identifying women at-risk for postpartum depression in the immediate postpartum period. Acta Psychiatr Scand. 2004;110:338–346.CrossRefGoogle ScholarPubMed
61.Benabarre, A, Vieta, E, Colom, F, Martinez-Aran, A, Reinares, M, Gasto, C. Bipolar disorder, schizoaffective disorder and schizophrenia: epidemiological, clinical and prognostic differences. Eur Psychiatry. 2001;16:167–172.Google Scholar
62.Sichel, DA, Cohen, LS, Robertson, LM, Ruttemberg, A, Rosenbaum, JF. Prophylactic estrogen in recurrent postpartum affective disorders. Biol Psychiatry. 1995;38:814–818.Google Scholar
63.Kumar, C, Mclvor, RJ, Davies, T, et al.Estrogen administration does not reduce the rate of recurrence of affective psychosis after childbirth, J Clin Psychiatry. 2003;64:112–118.CrossRefGoogle Scholar
64.Ahokas, A, Aito, M. Role of estradiol in puerperal psychosis. Psychopharmacology (Berl). 1999:147:108–110.Google Scholar
65.Ahokas, A, Aito, M, Turianen, S. Association between estradiol and puerperal psychosis. Acta Psychiatr Scand. 2000;101:167–169. discussion 169–170.Google Scholar
66.Gregoire, AJP, Kuman, R, Everitt, B, Henderson, AF, Studd, JW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet. 1996;347:930–933.Google Scholar
67.Cox, JL, Holden, JM, Sagovsky, R. Detection of postnatal depression: development of the 10 item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1897:150:782–786.Google Scholar
68.Murray, D. Oestrogen and postnatal depression. Lancet. 1996;347:918–919.Google Scholar
69.Ahokas, A, Turtainen, S, Aito, M. Sublingual oestrogen treatment of postnatal depression [letter]. Lancet. 1998;351:109.Google Scholar
70.Ahokas, A, Kaukoranta, J, Aito, M. Effect of oestradiol on postpartum depression. Psychopharmacology (Berl). 1999;146:108–110.Google Scholar
71.Overall, JE, Gorham, DR. The Brief Psychiatric Rating Scale. Psychol Rep. 1962;10:799–812.CrossRefGoogle Scholar
72.Ahokas, A, Kaukoranta, J, Wahlbeck, K, Aito, M. Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17β-estradiol. A preliminary study. J Clin Psychiatry. 2001;62:332–336.Google Scholar
73.Montgomery, SA, Asberg, MC. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–389.CrossRefGoogle ScholarPubMed
74.Grigoriadis, S, Kennedy, SH. Role of estrogen in treatment of depression. Am J Ther. 2002;9(6):503–509.Google Scholar
75.Soares, NC, Joffe, H, Cohen, LS, Almeida, OP. Efficacy of 17β-Estradiol on depression: is estrogen deficiency really necessary [letter]? J Clin Psychiatry. 2002;63:451.CrossRefGoogle ScholarPubMed
76.Cattel, DL, King, EA. Estrogen for postnatal depression. J Fam Pract. 1966;43:22–23.Google Scholar
77.Flores, DL, Hendrick, VC. Etiology and treatment of postpartum depression. Curr Psychiatry Rep. 2002;4:461–466.CrossRefGoogle ScholarPubMed
78.Parry, BL, Treatment of postpartum depression. Primary Psychiatry. 2004;11:48–51.Google Scholar
79.Ball, DE, Morrison, P. Oestrogen transdermal patches for postpartum depression in lactating women-a case report. Cent Afr J Med. 1999;45:68–70.Google Scholar
80.Gjerdingen, D. The effectiveness of various postpartum treatments and the impact of antidepressant drugs on nursing infant. J Am Board Fam Pract. 2003;16:387–392.Google Scholar
81.Huber, TJ, Rollnik, J, Wilhelms, J, von zur Mulhen, A, Emrich, HM, Schneider, U. Estradiol levels in psychotics disorders. Psychoneuroendocrinohgy. 2001;26:27–35.CrossRefGoogle ScholarPubMed
82.Lawrie, TA, Herxheimer, A, Dalton, K. Oestrogens and progestogens for preventing and treating postnatal depression (Cochrane Review). In: The Cochrane Library, issue 3. Chichester, UK: John Wiley & Sons, Ltd; 2004.Google Scholar
83.Rettembacher, MA, Mechtcheriakov, S, Bergant, A, Brugger, A, Fleischhacker, WW, Improvement of psychosis during treatment with estrogen and progesterone in a patient with hypoestrogenemia. J Clin Psychiatry. 2004;65:275–277.Google Scholar
84.Karrupaswamy, J, Vlies, R. The benefit of oestrogens and progestogens in postnatal depression. J Obstet Gynaecol. 2003;23:341–346.Google Scholar
85.Marcus, SM, Flynn, HA, Blow, F, Barry, K. A screening study of antidepressant treatment rates and mood symptoms in pregnancy. Arch Women Ment Health. 2005;8:25–27.Google Scholar
86.Sharma, V. Pharmacotherapy of postpartum depression. Expert Opin Pharmacother. 2002;3:1421–1431.Google Scholar
87.MacQueen, G, Chokka, P. Special issue in the management of depression in women. Can J Psychiatry. 2004;49(3 suppl 1):27S–40S.Google Scholar
88.Wisner, KL, Perel, JM, Peindl, KS, Hanusa, BH, Piontek, CM, Findling, RL. Prevention of postpartum depression: a pilot randomized clinical trial. Am J Psychiatry. 2004;161:1290–1292.Google Scholar
89.Sunder, KR, Wisner, KL, Hanusa, BH, Perel, JM. Postpartum depression recurrence versus discontinuation syndrome observations ftom a randomized controlled trials. J Clin Psychiatry. 2004;65:1266–1268.Google Scholar
90.Suri, R, Burt, VK, Altshuler, LL, Zuckerbrow-Miller, J, Fairbanks, L. Fluvoxamine for postpartum depression. Am J Psychiatry. 2001;158:1739–1740.Google Scholar
91.Misri, S, Reebye, P, Corral, M, Milis, L. The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial. J Clin Psychiatry. 2004;65:1236–1241.Google Scholar
92.Appleby, L, Warner, R, Whitton, A, Faragher, B. A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. BMJ. 1997;314:932–936.Google Scholar
93.Cohen, LS, Viguera, AC, Bouffard, SM, Nonacs, RM, Morabito, C, Collins, MH. Venlafaxine in the treatment of postpartum depression. J Clin Psychiatry. 2001;62:592–596.Google Scholar
94.Nonacs, RM, Soares, CN, Viguera, AC, Pearson, K, Poitras, JR, Cohen, LS. Bupropion SR for the treatment of postpartum depression: a pilot study, Int J Neuropsychopharmocol. 2005;8:445–449.CrossRefGoogle ScholarPubMed
95.Newport, DJ, Owens, MJ, Knight, DL, Ragan, DL, Morgan, N, Nemeroff, CB, Stowe, ZN. Alterations in platelet serotonin transporter binding in women with postpartum onset major depression. J Psychiatry Res. 2004;38:467–473.Google Scholar
96.Gentile, S. SSRIs in pregnancy and lactation with emphasis on neurodevelopmental outcome. CNS Drugs. 2005;19:623–633.Google Scholar
97.Hendrick, V, Fukuchi, A, Altshuler, L, Widawski, M, Wertheimer, A, Brunhuber, MV. Use of sertraline, paroxetine and fluvoxamine by nursing infants. Br J Psychiatry. 2001;179:163–166.Google Scholar
98.Kristensen, JH, Hackett, LP, Kohan, R, Paech, M, Ilett, KF. The amount of fluvoxamine in milk is unlikely to be a cause of adverse effects in breastfed infants. Hum Lact. 2002;18:139–143.Google Scholar
99.Piontek, CM, Wisner, KL, Perel, JM, Peindl, KS. Serum fluvoxamine levels in breastfed infants. J Clin Psychiatry. 2001;62:111–113.Google Scholar
100.Howard, L, Hoffbrand, S, Henshaw, C, Boath, L, Bradley, E. Antidepressant prevention of postnatal depression. Cochrane Database Syst Rev. 2005;18:CDOO4363.Google Scholar
101.Gentile, S. The safety of newer antidepressants in pregnancy and lactation. Drug Saf. 2005;28:137–152.Google Scholar
102.Chabrol, H, Teissedre, F, Saint-Jean, M, Teisseyre, N, Roge, B, Mullet, E. Prevention and treatment of post-partum depression: a controlled randomized study on women at risk. Psychol Med. 2002;32:1039–1047.Google Scholar
103.Steinberg, SI, Bellavance, F. Characteristics and treatment of women with antenatal and postpartum depression. Int J Psychiatry Med. 1999;29:209–233.Google Scholar
104.Dennis, CL. Treatment of postpartum depression, parr 2: a critical review of nonbiological interventions. J Clin Psychiatry. 2004;65:1252–1265.Google Scholar
105.Gentile, S. Atypical antipsychotics in pregnancy and lactation. Ann Pharmacother. 2004;38(7/8):1265–1271.Google Scholar
106.Yoshida, K, Smith, B, Cragg, M, Kumar, R. Neuroleptic drugs in breast-milk: a study of pharmacokinetics and possible adverse effects in breast-fed infants. Psychol Med. 1998;28:81–91.Google Scholar
107.Whalleu, LJ, Blain, PG, Prime, K. Haloperidol secreted in breast milk. Br Med J (Clin Res Ed). 1981;282:1746–1747.Google Scholar